The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
REPROGRAM-02: A phase II-III study evaluating an induction treatment with regorafenib and metronomic chemotherapy before the second line chemotherapy in metastatic colorectal cancer.
 
Angelique Vienot
No Relationships to Disclose
 
Stefano Kim
Honoraria - Amgen; Merck Serono; MSD; Pfizer; SERVIER
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Novartis; Pfizer; Sanofi
 
Elodie Klajer
No Relationships to Disclose
 
Dewi Vernerey
Consulting or Advisory Role - AC BioScience; Apmonia Therapeutics; cellprothera; CURE51; Fondazione Smith Kline; GERCOR; HalioDx; INCYTE; INVECTYS; Janssen-Cilag; OSE Immunotherapeutics; Pfizer; Veracyte
Travel, Accommodations, Expenses - MSD
 
François Ghiringhelli
Honoraria - roche
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Roche/Genentech; Roche/Genentech
 
Christophe Tournigand
Consulting or Advisory Role - Bayer
Research Funding - Bayer (Inst)
(OPTIONAL) Uncompensated Relationships - Fondation APHP (Inst)
 
Romain Cohen
Honoraria - AstraZeneca/Daiichi Sankyo; AstraZeneca/Daiichi Sankyo; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology; Mylan; Pierre Fabre; SERVIER; SERVIER; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; Enterome; Exeliom Biosciences
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD Oncology; Mylan; SERVIER; SERVIER
 
Stéphanie Husson
No Relationships to Disclose
 
Jérôme Desrame
Travel, Accommodations, Expenses - Pfizer
 
Jean-Baptiste Bachet
Honoraria - Amgen; AstraZeneca; Bayer; Merck Serono; MSD Oncology; Pierre Fabre; SERVIER; Viatris
Consulting or Advisory Role - Abbvie; Acobiom; Amgen; Bayer; BMS; GlaxoSmithKline; Incyte; Merck Serono; MSD; Servier
Travel, Accommodations, Expenses - Amgen; Merck Serono; Roche; Sanofi; Servier
 
Asmahane Benmaziane
No Relationships to Disclose
 
Emilie Soularue
No Relationships to Disclose
 
Olivier Bouche
Consulting or Advisory Role - Amgen; Apmonia Therapeutics; Astellas Pharma; Astellas Pharma; Deciphera; MSD Oncology; Pierre Fabre; SERVIER; Takeda
Speakers' Bureau - Amgen; Deciphera; Merck Serono; MSD Oncology; Pierre Fabre; Servier
Travel, Accommodations, Expenses - MSD Oncology; Pierre Fabre; Servier
 
Claire Gallois
Consulting or Advisory Role - Merck; MSD; Pierre Fabre; SERVIER
Travel, Accommodations, Expenses - Pierre Fabre; SERVIER
 
Eric Assenat
No Relationships to Disclose
 
Aurelia Meurisse
No Relationships to Disclose
 
Magali Rebucci-Peixoto
No Relationships to Disclose
 
Christophe Borg
Consulting or Advisory Role - Bayer; MSD Oncology; Pierre Fabre; Roche/Genentech
Research Funding - Roche/Genentech (Inst)